BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
6.03
+0.02 (0.33%)
At close: Aug 1, 2025, 4:00 PM
6.10
+0.07 (1.16%)
After-hours: Aug 1, 2025, 7:23 PM EDT
United States Steel Employees
BioVie had 14 employees as of June 30, 2024. The number of employees decreased by 4 or -22.22% compared to the previous year.
Employees
14
Change (1Y)
-4
Growth (1Y)
-22.22%
Revenue / Employee
n/a
Profits / Employee
-$1,383,088
Market Cap
11.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 14 | -4 | -22.22% |
| Jun 30, 2023 | 18 | 5 | 38.46% |
| Jun 30, 2022 | 13 | 7 | 116.67% |
| Jun 30, 2021 | 6 | 2 | 50.00% |
| Jun 30, 2020 | 4 | -1 | -20.00% |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIVI News
- 9 days ago - BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology - GlobeNewsWire
- 11 days ago - BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors - GlobeNewsWire
- 5 weeks ago - BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD) - GlobeNewsWire
- 5 weeks ago - BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress - GlobeNewsWire
- 2 months ago - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025 - GlobeNewsWire
- 4 months ago - BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025 - GlobeNewsWire
- 6 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages BioVie Inc. (BIVI) Shareholders to Inquire about Securities Investigation - Accesswire
- 6 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating BioVie Inc. (BIVI) And Encourages Shareholders to Connect - Accesswire